Leonardi, Giulia C.
Dana-Farber Cancer Institute
3 papers on CoChatORCID 0000-0002-9532-0220
Most cited papers
- Verified
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
Skoulidis, F., Goldberg, M. E., Greenawalt, D. M., Hellmann, M. D., Awad, M. M., Gainor, J. F., Schrock, A. B., Hartmaier, R. J., Trabucco, S. E., Gay, L., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,641
- Verified
Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
Leonardi, G. C., Gainor, J. F., Altan, M., Kravets, S., Dahlberg, S. E., Gedmintas, L., Azimi, R., Rizvi, H., Riess, J. W., Hellmann, M. D., et al. (2018) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 341
- Verified
Ageing: from inflammation to cancer
Leonardi, G. C., Accardi, G., Monastero, R., Nicoletti, F., & Libra, M. (2018) · Immunity & Ageing
Genetics, Aging, and Longevity in Model OrganismsImmune cells in cancer
Cited by 241
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free